HBDt.Fc (Scripps)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHBDt.Fc (Scripps)
Drug Alias Nameradiolabelled recombinant VEGF 165 fusion protein (Scripps)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionNeuropilin 2 modulators
TargetsNeuropilin 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Scripps Research Institute Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Scripps Research Institute Inc
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A